Specialty Pharmacy News Roundtable

NICK SARANITI, COMMCARE: I come from probably the worst- paying Medicaid state and … especially in that HIV space, on drugs like Selzentry or Fuzeon, we’ve seen the state put prior authorization and other hurdles in place across the Medicaid program mandating that genetic testing be conducted and the requirements of the PI be met.

Read More Specialty Pharmacy News Roundtable

Balancing Big and Small

You could say Nicholas Saraniti’s company has split personalities. From the inside, it looks like a growing corporation with high-tech systems and structures. But looking in on Commcare Pharmacy from a customer’s perspective, it seems like the small company it’s always been.

Read More Balancing Big and Small

Commcare Pharmacy named an Inc. 500 Company

Commcare Pharmacy CEO, Nicholas Saraniti, stated that “It’s truly an honor to have our achievements recognized by other entrepreneurs. Commcare continues to evolve and adapt it’s practices in order to provide our clients best in class Specialty Pharmacy services in a very competitive channel. We expect this evolution to continue as the entire healthcare industry is reassessed in the coming months”.

Read More Commcare Pharmacy named an Inc. 500 Company

Spotlight On Commcare Pharmacy

“We recognized a few years back that the market for specialty pharmacy was also expanding,” says Nicholas Saraniti who heads up operations, sales and marketing for the company. Nicholas added, “Our business and clinical model were well established and these core competencies were easily transferable to other therapeutic categories. Today we are very strong in RA, MS, and HepC to name a few. In 2006 we saw the Oral Oncology market take off and we successfully built a position in that high growth segment. Clearly our reputation in the southeast region – especially within the prescriber community and with manufacturers – was a real asset.”

Read More Spotlight On Commcare Pharmacy

Commcare Pharmacy Completes Acquisition of Pulmonary Prescription Providers

Commcare Pharmacy CEO Nicholas Saraniti stated that “This acquisition allows Commcare to offer a full suite of Infusion Services to our current clients, while adding substantial SP services in RSV and Dialysis ”. With the completion of the acquisition, Commcare Pharmacy now offers services to HIV/AIDS, Oncology, Hepatitis, Transplant, RSV, Infusion, Dialysis, Enteral, MS, Crohn’s, and Arthritis Patients.

Read More Commcare Pharmacy Completes Acquisition of Pulmonary Prescription Providers